Click to Enlarge
Facebook
Twitter
The positive effect of Pfizer’s Paxlovid pill on investment in the stock market is the main story for the Financial Times. Following the announcement of the new treatment’s success in clinical trials, there was a “sharp rally” in share prices for companies most impacted by the pandemic, the paper reports.